ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 91 filers reported holding ADMA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 4.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,580 | -3.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2023 | $3,690 | +11.5% | 1,000 | 0.0% | 0.00% | – |
Q1 2023 | $3,310 | -14.7% | 1,000 | 0.0% | 0.00% | – |
Q4 2022 | $3,880 | +94.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -80.0% | 1,000 | -75.0% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 4,000 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -100.0% | 4,000 | -50.0% | 0.00% | – |
Q1 2021 | $14,080,000 | +175900.0% | 8,000 | +100.0% | 0.00% | – |
Q4 2020 | $8,000 | -20.0% | 4,000 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | +233.3% | 4,000 | +300.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |